Expression of transcription factor AML-2 (RUNX3, CBFα-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype

Journal of Virology

Volumn 76, Issue 10, 2002, Pages 4919-4927

  Spender, Lindsay C ^a   Cornish, Georgina H ^a   Sullivan, Alexandra ^a   Farrell, Paul J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 16; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AML 1; TRANSCRIPTION FACTOR AML 2; TRANSCRIPTION FACTOR EBNA 2; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS LATENCY;

B-LYMPHOCYTES; BURKITT LYMPHOMA; CARRIER PROTEINS; CELL LINE; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-16; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VIRUS LATENCY;

EID: 0036232830     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.10.4919-4927.2002     Document Type: Article

References (68)

1. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor
2. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75)
3. BAX frameshift mutations in cell lines derived from human haemopoetic malignancies are associated with resistance to apoptosis and microsatellite instability
4. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B cells
5. The expression pattern of the AML1 gene in non-Hodgkin's B-cell lymphomas and normal B lymphocytes
6. Tissue and T-cell distribution of precursor and mature IL-16
7. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
8. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation
9. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
10. ETS-core binding factor: A common composite motif in antigen receptor gene enhancers
11. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions
12. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
13. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription
14. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype
15. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter
16. Epstein-Barr virus nuclear protein LP (EBNA-LP) stimulates EBNA-2 acidic domain mediated transcriptional activation
17. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein JK
18. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus
19. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: Implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells
20. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by JK and PU.1
21. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2
22. B lymphocyte-derived IL-16 attracts dendritic cells and Th cells
23. 1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2
24. Epstein-Barr virus and its replication
25. Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family
26. Overexpression of the AML1 proto-oncoprotein in NIH 3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies
27. The Spi-1/ PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-Jκ interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element
28. Regulation of AML2/ CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway
29. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors
30. AML1, AML2, and AML3, the human members of the Runt domain gene-family: cDNA structure, expression, and chromosomal localization
31. AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter
32. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1
33. Epstein-Barr virus-encoded protein found in plasma membrane in transformed cells
34. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia
35. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript
36. A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1,11 and 14
37. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation
38. Epstein-Barr virus leader protein (EBNA-LP) enhances EBNA-2 mediated transactivation of latent membrane protein 1 expression; a role for the W1W2 repeat domain
39. A phorbol ester response element within the human T-cell receptor beta-chain enhancer
40. Non-immortalizing P3J-HR-1 Epstein-Barr virus: A deletion mutant of its transforming parent, Jijoye
41. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells
42. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
43. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
44. Cultured human fibroblasts express constitutive IL-16 mRNA: Cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism
45. Human B-cell lines constitutively express and secrete interleukin-16
46. CBF α3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter
47. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus
48. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter
49. Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus
50. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection
51. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen
52. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2
53. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability
54. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction
55. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2
56. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE
57. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein
58. AML1A and AML1B can transactivate the human IL-3 promoter
59. The human Jκ Recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements
60. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
61. Mammalian Runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia
62. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Inil
63. Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2
64. Identification of a region which directs the monocytic activity of the colony-stimulating factor I (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)
65. Processing and activation of pro-interleukin-16 by caspase-3
66. Transcriptional regulation of the transforming growth factor-beta-inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members
67. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival
68. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter